Refractory heart failure: it requires the use of polychemotherapy. what is the rationale?
Campa, P.P.; Puddu, P.E.; Schiariti, M.; Monti, F.; Dawodu, A.A.; Gentile, C.; Lilla Della Monica, P.L.; Vaccaro, M.; De Biase, L.
Cardiologia 40(12 Suppl 1: 139-150
1995
ISSN/ISBN: 0393-1978 PMID: 8998706 Document Number: 440750
Document emailed within 1 workday
Related Documents
Nimis, R. 1975: Refractory heart failure Minerva Cardioangiologica 23(2): 105-112Hulsey, R. 1971: Glucagon in refractory heart failure Arizona Medicine 28(4): 288-290
Noble, R.J. 1977: An approach to refractory heart failure American Family Physician 15(4): 138-147
Hartmann, A.; Schneider, W.; Schneider, M.; Kaltenbach, M. 1988: Amyloidosis as a cause of therapy refractory heart failure Medizinische Klinik 83(20): 655-659
Ryckelynck, J.P.; Lobbedez, T.; Valette, B.; Le Goff, C.; Mazouz, O.; Levaltier, B.; Potier, J.C.; Hurault de Ligny, B. 1997: Peritoneal ultrafiltration and refractory congestive heart failure Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 13: 93-97
Takatsu, T.; Morita, H.; Kubo, S.; Sonotani, N.; Nishioka, A.; Noda, S.; Imamura, K.; Hirota, Y.; Kitaura, Y.; Tsutsumi, J.; Kawamura, K. 1978: Idiopathic cardiomyopathy in refractory congestive heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 36(7): 2802-2822
Mangiavacchi, M.; Gronda, E. 2003: Inotropic agents in advanced and refractory heart failure Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 4(1): 3-7
Radhakrishnan, S.; Krishnaswamy, M.; Bose, S.C. 1978: Waldenstrom's macroglobulinaemia, presenting as refractory congestive heart failure Journal of the Association of Physicians of India 26(8): 754-757
Hertzeanu, H.; Pines, A. 1988: New inotropic agents in the treatment of refractory congestive heart failure Harefuah 114(6): 290-293
Cipolla, C.M.; Rimondini, A.; Della Bella, P.; Fabbiocchi, F.; Grazi, S.; Marenzi, G.; Sganzerla, P.; Tondo, C.; Sisillo, E.; Susini, G. 1987: Acute treatment of refractory congestive heart failure using hemofiltration Cardiologia 32(1): 69-72
King, J.F.; Salel, A.F.; Amsterdam, E.A.; Massumi, R.A.; Zelis, R.; Mason, D.T. 1973: Recent advances in therapy for refractory congestive heart failure Geriatrics 28(3): 94-102
Hoffmann, P.; Schockenhoff, B. 1985: Amrinone in catecholamine refractory heart failure in septic shock Der Anaesthesist 34(12): 663-669
Mortensen, S.Aage. 2003: Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial Biofactors 18(1-4): 79-89
Kensey, K. 2003: How should diuretic-refractory, volume-overloaded heart failure patients be managed? Journal of Invasive Cardiology 15(12): A17
Wang, Z.S. 1983: A clinical study on treatment of refractory heart failure with oral captopril Zhonghua Xin Xue Guan Bing Za Zhi 11(4): 269-272
Sackner-Bernstein, J.D.; Obeleniene, R. 2003: How should diuretic-refractory, volume-overloaded heart failure patients be managed? Journal of Invasive Cardiology 15(10): 585-590
Nikolić, V.; Planinc, D.; Rudar, M.; Pagon, L. 1987: Can prazosin be used in the treatment of refractory heart failure only on the basis of clinical monitoring? Wiener Medizinische Wochenschrift 137(1): 9-13
Misler, S.; Nidus, B.D. 1984: Long-term ultrafiltration as a treatment of refractory congestive heart failure New York State Journal of Medicine 84(10): 518-520
Borbolla-Escoboza, J.R.; López-Hernández, M.A.; González-Avante, M.; DeDiego, J.; Trueba-Christy, E.; Anaya-Cuéllar, I. 1998: Comparison of 2 regimens of polychemotherapy in refractory acute leukemia or in relapse Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(4): 307-310
Valle, B.K.; Valle, G.A.; Lemberg, L. 1995: Volume control: a reliable option in the management of 'refractory' congestive heart failure American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 4(2): 169-173